Fred Hutch statement regarding the FDA approval of CD19 immunotherapy, lisocabtagene maraleucel
Hutch News,
SEATTLE — Feb. 5, 2021 — Today the U.S. Food and Drug Administration approved the chimeric antigen receptor immunotherapy…
SEATTLE — Feb. 5, 2021 — Today the U.S. Food and Drug Administration approved the chimeric antigen receptor immunotherapy…
Post Views: 1 SEATTLE Feb. 5, 2021 Today the U.S. Food and Drug Administration approved the chimeric antigen receptor…
Introduction Chimeric antigen receptors (CARs) were originally devised by recombining antibody variable regions with TCR…